Biochemical studies of serum markers in Egyptian patients with non-small cell lung cancer (NSCLC)

BACTERIAL INFECTION PROFILES AND TUMOR BIOMARKERS IN EGYPTIAN LUNG CANCER PATIENTS

Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute

INTER-TUMOR HETEROGENEITY OF PD-L1 EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER AND ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA AMONG PATIENTS IN ALEXANDRIA, EGYPT

INTER-TUMOR HETEROGENEITY OF PD-L1 EXPRESSION IN ADVANCED ‎NON-SMALL CELL LUNG CANCER AND ADVANCED HEAD AND NECK ‎SQUAMOUS CELL CARCINOMA AMONG PATIENTS IN ALEXANDRIA, ‎EGYPT .

Association of TP53 codon 72 polymorphisms and non-small cell lung cancer risk in the Egyptian population: a case-control study

Outcome of Patients with Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases: Egyptian Experience

Patterns of Care and Treatment Pathways for Non-Surgically Managed Early and Locally Advanced Non-Small Cell Lung Cancer Patients at Ain Shams University Clinical Oncology Departm

SERUM LONG NON-CODING RNA MALAT1 AS POTENTIAL BIOMARKER FOR BREAST CANCER IN EGYPTIAN FEMALE PATIENTS

Frequency of ALK gene rearrangement and its association with survival rate among Upper Egypt Non-Small cell lung cancer patients